The James J. Peters VA Medical Center, is a US Department of Veterans Affairs hospital complex located at 130 West Kingsbridge Road in West Fordham, Bronx, New York City. The hospital is the headquarters of the Veterans Integrated Service Networks New York/New Jersey VA Health Care Network.

There are 311 beds in James J. Peters VA Medical Center.

During the past decade, James J. Peters VA Medical Center conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 33 clinical trials were completed, i.e. on average, 34% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 20 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James J. Peters VA Medical Center" #1 sponsor was "VA Office of Research and Development" with 45 trials, followed by "James J. Peters Veterans Affairs Medical Center" with 29 trials sponsored, "National Cancer Institute (NCI)" with 12 trials sponsored, "Bronx VA Medical Center" with 9 trials sponsored and "Bristol-Myers Squibb" with 9 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James J. Peters VA Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Kessler Institute for Rehabilitation" with 8 trials as a collaborator, "James J. Peters Veterans Affairs Medical Center" with 6 trials as a collaborator, "Icahn School of Medicine at Mount Sinai" with 4 trials as a collaborator and "Kessler Foundation" with 4 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "James J. Peters VA Medical Center" are "Spinal Cord Injury" (25 trials), "Spinal Cord Injuries" (16 trials), "Neurogenic Bowel" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (4 trials) and "Stage IV Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "James J. Peters VA Medical Center" in a lesser frequency.

Most popular intervention types in "James J. Peters VA Medical Center" are "Drug" (72 trials), "Other" (37 trials), "Device" (23 trials), "Behavioral" (22 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Quality-of-Life Assessment" (8 trials), "Questionnaire Administration" (7 trials), "Laboratory Biomarker Analysis" (6 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "James J. Peters VA Medical Center" are 132 trials for "All" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "James J. Peters VA Medical Center". 2 are not yet recruiting, 34 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in James J. Peters VA Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in James J. Peters VA Medical Center, 10 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 52 trials that are defined as “Not Applicable".